Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

uad laboratories - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520) - tablet - 650 mg - acetaminophen and codeine phosphate tablets are indicated for the relief of mild to moderately severe pain. this product should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. acetaminophen and codeine phosphate tablets are classified as a schedule iii controlled substance. codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence. and tolerance may develop upon repeated administration and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

mylan institutional inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated for: - all children younger than 12 years of age [see warnings ]. - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see warnings ]. acetaminophen and codeine phosphate tablets are contraindicated in patients with: - significant respiratory depression [see warnings ].

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

pharmaceutical associates, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520) - solution - acetaminophen and codeine phosphate oral solution is indicated for the relief of mild to moderate pain. this product should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen. acetaminophen and codeine phosphate oral solution is classified as a schedule v controlled substance. codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. psychological dependence, physical dependence, and tolerance may develop upon repeated administration and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

haleon ireland limited - paracetamol; codeine phosphate hemihydrate - film-coated tablet - 500/12.8 milligram(s) - codeine and paracetamol

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - codeine phosphate hemihydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose monohydrate; docusate sodium; povidone; potato starch - for the relief of acute moderate pain and fever.

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; codeine phosphate hemihydrate; caffeine - effervescent tablet - 500 /12.8 /30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - codeine phosphate hemihydrate, quantity: 5 mg/ml - oral liquid - excipient ingredients: glycerol; propylene glycol; purified water; sucrose; methyl hydroxybenzoate - relief of unproductive, dry and intractable coughs associated with colds and flu relief of unproductive, dry and intractable coughs associated with colds and flu.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - codeine phosphate hemihydrate, quantity: 8 mg; aspirin, quantity: 300 mg - tablet, dispersible - excipient ingredients: citric acid; wheat starch; purified talc; saccharin sodium; calcium carbonate; disodium edetate; sodium lauryl sulfate - for the temporary relief of acute moderate pain, inflammation and fever

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - ibuprofen; codeine phosphate hemihydrate - film-coated tablet - 200/12.8 milligram(s) - opioids in combination with non-opioid analgesics; codeine and ibuprofen

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; codeine phosphate hemihydrate; caffeine - effervescent tablet - 500 mg/8 mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol